Advertisement

Legal and Regulatory

HHS’ Office on Women’s Health has launched an initiative with the Agency for Healthcare Research and Quality aimed at improving breast cancer screening and diagnostic follow-up for women in midlife. As part of the initiative, the agencies will examine how…

Cleveland Clinic Cancer Institute has established a task force to evaluate AI tools and streamline their adoption into operations and clinical care.  The task force, called the Cancer Institute Office of Technology and Digital Strategy, is led by oncologists Paul…

The FDA has granted accelerated approval to an immunotherapy that may spare some patients with locally advanced rectal cancer from undergoing chemotherapy, radiation and surgery. The approval covers London-based GSK’s dostarlimab-gxly — sold under the brand name Jemperli — as…

The FDA on Oct. 8 approved Genentech’s Tecentriq (atezolizumab) with chemotherapy as an adjuvant treatment for adults and children ages 2 and older with stage 3 mismatch repair-deficient colon cancer. The approval covers Tecentriq combined with a fluoropyrimidine and oxaliplatin.…

A coalition of Texas health systems, professional organizations and community groups has launched a five-year plan to eliminate cervical cancer in the state. The Texas Lone Star Cervical Cancer Elimination Plan 2027-2032 was developed by the Cancer Alliance of Texas…

Advertisement

HHS has appointed Michael Caputo, a former adviser to the Trump administration, to serve on the President’s Cancer Panel.  The President’s Cancer Panel was established in 1971 through the National Cancer Act and monitors the activities of the National Cancer…

A pivotal year for cancer blood tests An FDA advisory panel voted Sept. 23 in favor of approving Grail’s Galleri multi-cancer early detection blood test, marking the first time a blood test of this kind has reached that stage of…

Of 532 hospitals, Detroit-based Karmanos Cancer Center was the only cancer center to achieve a catheter-associated urinary tract infection rate of zero between Oct. 1, 2024, and Sept. 30, 2025, according to CMS data published Aug. 13.  Catheter-associated urinary tract…

The Cigna Group is partnering with OpenAI to integrate AI into clinical workflows, with a first focus on cancer care. Under the collaboration announced Sept. 23, OpenAI’s tools will be built into workflows across Accredo Specialty Pharmacy and the insurance…

The National Cancer Institute will need about $9.7 billion to maintain and strengthen operations in fiscal year 2028, according to the institute’s “Annual Plan and Professional Judgment Budget,” published Sept. 2. Here are three notes on the budget: Read NCI’s…

Advertisement